Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

West Pharmaceutical Services (WST) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 6,109,400
  • Shares Outstanding, K 73,220
  • Annual Sales, $ 1,400 M
  • Annual Income, $ 96 M
  • 36-Month Beta 0.95
  • Price/Sales 4.40
  • Price/Book 5.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
76.87 +9.55%
on 11/14/16
84.98 -0.91%
on 12/09/16
+6.65 (+8.57%)
since 11/09/16
3-Month
70.17 +20.01%
on 10/26/16
84.98 -0.91%
on 12/09/16
+4.02 (+5.01%)
since 09/09/16
52-Week
53.88 +56.29%
on 02/08/16
84.98 -0.91%
on 12/09/16
+21.38 (+34.03%)
since 12/09/15

Most Recent Stories

More News
West Announces Expanded Contract Manufacturing Capabilities in Ireland

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract...

SmarTrend Watching for Potential Pullback in Shares of West Pharmaceutical Services After 2.58% Gain

West Pharmaceutical Services (NYSE:WST) traded in a range yesterday that spanned from a low of $72.76 to a high of $75.72. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day...

West Announces Third Quarter 2016 Results

West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for full-year...

Dental Stocks' Earnings to Watch on Oct 27: MCK, WST, CNMD

Following are a few dental stocks that are gearing up to beat earnings this quarter.

Research Reports Initiation on Healthcare Stocks -- Hill-Rom, Waters, Halyard Health, and West Pharma

Revenue in the U.S. Medical Instruments and Supplies space is forecasted to continue growing in the coming years due to favorable demographic and technological trends. Through 2021, the segment's industry...

Pharmaceutical & Healthcare Leaders Collaborate to Improve the Patient Journey

End-to-End Self-Injection Platform to Improve Adherence Showcased at 2016 PDA Universe of Pre-filled Syringes and Injection Devices

Pharmaceutical & Healthcare Leaders Collaborate to Improve the Patient Journey

End-to-End Self-Injection Platform to Improve Adherence Showcased at 2016 PDA Universe of Pre-filled Syringes and Injection Devices

West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices

(Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it will participate in several...

West to Host Third Quarter 2016 Conference Call

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third quarter 2016 financial results before...

West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed David A. Montecalvo to serve as Senior Vice...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

West Pharmaceutical Services applies technologies to the process of bringing new drug therapies and healthcare products. West's technologies include the design and manufacture of packaging components for pharmaceutical, healthcare and consumer products; research and development of drug delivery systems;...

See More

Support & Resistance

2nd Resistance Point 85.54
1st Resistance Point 84.88
Last Price 84.21
1st Support Level 83.65
2nd Support Level 83.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.